RESUMEN
INTRODUCTION: Mastocytosis is a rare and heterogenous disease, and in children it is generally limited to the skin and tends to regress spontaneously in adolescence. AIM: In this study, demographic, clinical, and laboratory characteristics of pediatric patients with mastocytosis, and also coexisting diseases were investigated. RESULTS: A total of 61 pediatric patients were included in the study. The male-to-female ratio was 2.2, the median age was 2 years (range, 0.25 to 19 y), and the median follow-up period was 2.0 years (range, 0.25 to 19 y). Types of clinical presentation at diagnosis consisted of mainly urticaria pigmentosa (45.9%). Seven patients were further investigated with suspicion of systemic mastocytosis, they were followed up, median of 9 years (range, 2.5 to 16 y), and none of them developed systemic disease. Coexisting allergic diseases were recorded in total 5 patients (8.2%). Three patients had immunoglobulin A deficiency, 1 patient had elevated immunoglobulin E level. A patient developed mature B-cell lymphoma with a heterozygous mutation in c-KIT exon 11. DISCUSSION: Cutaneous mastocytosis in children may present as a complex disease with different clinical signs and symptoms. Standardized clinical criteria and guidelines for the follow-up of children with mastocytosis are required.
Asunto(s)
Urticaria Pigmentosa/sangre , Urticaria Pigmentosa/terapia , Adolescente , Adulto , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino , Estudios Retrospectivos , Urticaria Pigmentosa/patologíaRESUMEN
Mastocytosis is a heterogeneous disease of bone marrow origin, characterized by local or diffuse increased growth and accumulation of clonal mast cells in the skin and/or in internal organs. The skin is the organ most frequently involved, but others may be affected as well. The purpose of this article is to present the oral management of a child with urticaria pigmentosa/maculopapulous cutaneous mastocytosis requiring dental treatment under general anesthesia. The multidisciplinary team approach involving the relevant medical specialists is discussed to emphasize the significance of coordinated patient management.
Asunto(s)
Mastocitosis Cutánea , Mastocitosis , Urticaria Pigmentosa , Niño , Humanos , Mastocitos , Mastocitosis Cutánea/terapia , Urticaria Pigmentosa/terapiaRESUMEN
Mastocytosis is a rare disease characterised by expansion and collection of clonal mast cells in various organs including the skin, bone marrow, spleen, lymph nodes and gastrointestinal tract. The prevalence of mastocytosis has been estimated to be one in 10 000, while the estimated incidence is one per 100 000 people per year. Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigmentosa; (ii) diffuse cutaneous mastocytosis; and (iii) mastocytoma of the skin. In adults, cutaneous lesions are usually associated with indolent systemic mastocytosis and have a chronic evolution. Paediatric patients, on the contrary, have often cutaneous manifestations without systemic involvement and usually experience a spontaneous regression. Diagnosis of cutaneous mastocytosis may be challenging due to the rarity of the disease and the overlap of cutaneous manifestations. This short review describes pathogenesis and clinical aspects of cutaneous mastocytosis with a focus on diagnosis and currently available therapies.
Asunto(s)
Mastocitosis Cutánea/diagnóstico , Mastocitosis Cutánea/terapia , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/terapia , Predisposición Genética a la Enfermedad , Humanos , Mastocitosis Cutánea/complicaciones , Fosfolipasas/sangre , Rol del Médico , Pronóstico , Piel/patología , Triptasas/sangre , Urticaria Pigmentosa/complicacionesRESUMEN
We had our suspicions as to the diagnosis, but a particular sign was missing. The biopsy settled things.
Asunto(s)
Piel/patología , Urticaria Pigmentosa/diagnóstico , Biopsia , Preescolar , Femenino , Humanos , Urticaria Pigmentosa/etiología , Urticaria Pigmentosa/patología , Urticaria Pigmentosa/terapiaRESUMEN
BACKGROUND/OBJECTIVES: Urticaria pigmentosa (UP) is the most common form of mastocytosis in children and is associated with systemic signs, symptoms, and triggers. To our knowledge, the effect of UP on children's quality of life has not been studied. The objective of the current study was to characterize the natural history, triggers, and complications of pediatric UP, identify prognostic indicators, and determine its effect on quality of life. METHODS: Between 2002 and 2007, children with three or more mastocytomas diagnosed by a pediatric dermatologist were recruited during visits at the Children's Hospital of Wisconsin Dermatology Clinic (Milwaukee, WI). Research visits were conducted every 3 years and telephone interviews yearly. The Children's Dermatology Life Quality Index was administered to subjects 4 years of age and older at enrollment. Laboratory test results were collected for subjects younger than 4 years at enrollment. Subjects were followed until UP resolution or study end in August 2015. RESULTS: The final cohort size was 43 subjects followed for a median of 8.1 years. Twenty-six subjects were followed through study completion. At age 12 years, 6 patients had disease resolution and 14 remained active. Patients who had disease resolution before age 12 years were more likely to be male and had fewer years of age and smaller lesions, fewer affected areas, and earlier onset. Common medications and anesthetics resulted in no serious reactions. Hymenoptera stings occurred in 51%, with no reports of anaphylaxis. No patient reported a severe effect on quality of life, with most indicating mild to no effect. CONCLUSION: Severe complications are not common with historically identified triggers. Disease does not resolve before adolescence in most children. UP has a minimal effect on quality of life for most children.
Asunto(s)
Urticaria Pigmentosa/complicaciones , Urticaria Pigmentosa/diagnóstico , Niño , Preescolar , Femenino , Humanos , Lactante , Estudios Longitudinales , Masculino , Estudios Prospectivos , Calidad de Vida , Factores de Riesgo , Urticaria Pigmentosa/terapiaRESUMEN
Urticaria pigmentosa, also known as maculopapular mastocytosis, is the most common type of paediatric mastocytosis. It presents with yellow to brown macules or papules, usually located on trunk and extremities. Regarding its diagnostic and therapeutic implications, the objective of this article is to serve as an update for the paediatrician on the most relevant aspects of this pathology.
La urticaria pigmentosa, también conocida como mastocitosis maculopapular, es el tipo de mastocitosis más común en la edad pediátrica. Se presenta con máculas o pápulas de color amarillo-marrón, usualmente localizadas en el tronco y las extremidades. Considerando sus implicancias diagnósticas y terapéuticas, el objetivo de este artículo es brindar al pediatra una actualización de los aspectos más relevantes de esta patología.
Asunto(s)
Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/terapia , Niño , Humanos , PediatríaRESUMEN
Introducción La mastocitosis representa un grupo de enfermedades caracterizadas por una acumulación excesiva de mastocitos en uno o múltiples tejidos. Puede limitarse a la piel o tener un compromiso sistémico, siendo de baja prevalencia y pronóstico benigno en la infancia. Objetivo Reportar un caso de urticaria pigmentosa como subtipo de mastocitosis cutánea y hacer una revisión bibliográfica enfocada en los hallazgos clínicos, el diagnóstico y el manejo inicial básico. Caso clínico Lactante de 6 meses de edad con múltiples máculas y pápulas de color café claro localizadas en el tronco, los brazos y las piernas, cuadro compatible con una urticaria pigmentosa, confirmada mediante biopsia. Se solicitaron exámenes para descartar compromiso sistémico. La paciente fue tratada con medidas generales, educación y antihistamínicos, con excelente evolución. Conclusiones La mastocitosis cutánea es una enfermedad poco común, de buen pronóstico. En la infancia generalmente bastan las medidas generales y educación para obtener resultados favorables. La terapia farmacológica de primera línea son los antagonistas H1.
Introduction Mastocytosis represents a group of diseases characterised by an excesive accumulation of mastocytes in one or multiple tissues. It can affect only the skin, or have a systemic involvement. It has a low prevalence, and the prognosis is benign in children. Objective To report a case of urticaria pigmentosa as a subtype of cutaneous mastocytosis, and present a literature review focused on clinical findings, diagnosis and initial basic management. Clinical case A child of six months of age presenting with multiple blemishes and light brown papules located on the trunk, arms and legs. The symptoms were compatible with urticaria pigmentosa, and was confirmed by biopsy. Tests to rule out systemic involvement were requested. The patient was treated with general measures, education, and antihistamines, with favourable results. Conclusions Cutaneous mastocytosis is a rare disease with a good prognosis. In childhood general measures and education are usually enough to obtain favourable results. Histamine H1 antagonists are the first line drug treatment.
Asunto(s)
Humanos , Femenino , Lactante , Urticaria Pigmentosa/diagnóstico , Mastocitosis Cutánea/diagnóstico , Pronóstico , Biopsia , Urticaria Pigmentosa/patología , Urticaria Pigmentosa/terapia , Mastocitosis Cutánea/patología , Mastocitosis Cutánea/terapia , Antagonistas de los Receptores Histamínicos H1/uso terapéuticoRESUMEN
INTRODUCTION: Mastocytosis represents a group of diseases characterised by an excesive accumulation of mastocytes in one or multiple tissues. It can affect only the skin, or have a systemic involvement. It has a low prevalence, and the prognosis is benign in children. OBJECTIVE: To report a case of urticaria pigmentosa as a subtype of cutaneous mastocytosis, and present a literature review focused on clinical findings, diagnosis and initial basic management. CLINICAL CASE: A child of six months of age presenting with multiple blemishes and light brown papules located on the trunk, arms and legs. The symptoms were compatible with urticaria pigmentosa, and was confirmed by biopsy. Tests to rule out systemic involvement were requested. The patient was treated with general measures, education, and antihistamines, with favourable results. CONCLUSIONS: Cutaneous mastocytosis is a rare disease with a good prognosis. In childhood general measures and education are usually enough to obtain favourable results. Histamine H1 antagonists are the first line drug treatment.
Asunto(s)
Mastocitosis Cutánea/diagnóstico , Urticaria Pigmentosa/diagnóstico , Biopsia , Femenino , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Lactante , Mastocitosis Cutánea/patología , Mastocitosis Cutánea/terapia , Pronóstico , Urticaria Pigmentosa/patología , Urticaria Pigmentosa/terapiaAsunto(s)
Betametasona/administración & dosificación , Antagonistas de los Receptores Histamínicos/administración & dosificación , Terapia PUVA/métodos , Urticaria Pigmentosa , Administración Tópica , Preescolar , Diagnóstico Diferencial , Manejo de la Enfermedad , Femenino , Glucocorticoides/administración & dosificación , Humanos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/patología , Urticaria Pigmentosa/fisiopatología , Urticaria Pigmentosa/terapiaRESUMEN
Urticaria pigmentosa is the most common form of mastocytosis. Mastocytosis usually presents at birth or early childhood, and may involve only the skin or, less commonly, other internal organs. Diagnosis is clinical, but a skin biopsy may be useful. Prognosis is usually good, and treatment focuses on the avoidance of certain triggers and administration of topical and systemic medications. Appropriate counselling of parents regarding the benign nature of this disease is important as most cases resolve by adolescence.
Asunto(s)
Urticaria Pigmentosa/diagnóstico , Edad de Inicio , Biopsia , Humanos , Lactante , Masculino , Pronóstico , Urticaria Pigmentosa/terapiaAsunto(s)
Mastocitosis Cutánea/patología , Xantomatosis/patología , Biopsia con Aguja , Terapia Combinada , Diagnóstico Diferencial , Femenino , Humanos , Inmunohistoquímica , Lactante , Mastocitosis Cutánea/diagnóstico , Mastocitosis Cutánea/terapia , Enfermedades Raras , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/patología , Urticaria Pigmentosa/terapia , Xantomatosis/diagnóstico , Xantomatosis/terapiaRESUMEN
During the last three decades, ultraviolet A1 (UVA1) phototherapy has emerged as a specific phototherapeutic modality with distinct modes of action and some well established indications. Atopic dermatitis, localized scleroderma, and systemic lupus erythematosus seem to be the conditions with the best evidence regarding efficacy and safety of UVA1 phototherapy. Further indications for UVA1 include subacute prurigo, lichen sclerosus, dyshidrotic dermatitis, cutaneous T cell lymphoma, urticaria pigmentosa, and pityriasis rosea; nevertheless, there are some unknowns, uncertainties, and controversies concerning short- and long-term side effects, efficacy and dosage regimens of UVA1 phototherapy in some conditions. We describe and discuss treatment regimens, protocols, dosage, and indications for UVA1 phototherapy.
Asunto(s)
Fototerapia , Enfermedades de la Piel/terapia , Terapia Ultravioleta/métodos , Dermatitis Atópica/terapia , Humanos , Liquen Escleroso y Atrófico/terapia , Lupus Eritematoso Sistémico/terapia , Guías de Práctica Clínica como Asunto , Dosificación Radioterapéutica , Esclerodermia Localizada/terapia , Factores de Tiempo , Resultado del Tratamiento , Terapia Ultravioleta/efectos adversos , Urticaria Pigmentosa/terapiaRESUMEN
Cutaneous mastocytosis in children is a generally benign disease that can present at birth and is often associated with mast cell mediator-related symptoms including pruritus, flushing, and abdominal pain with diarrhea. The most common form of presentation is urticaria pigmentosa, also referred to as maculopapular mastocytosis. Flares of lesions are induced by triggers such as physical stimuli, changes in temperature, anxiety, medications, and exercise. The skin lesions are typically present on the extremities. Symptoms respond to topical and systemic anti-mediator therapy including antihistamines and cromolyn sodium. Remission at puberty is seen in a majority of cases. Progression to systemic mastocytosis with involvement of extracutaneous organs is not common. The cause of cutaneous mastocytosis is unknown and familial cases are rare. Mutations of c-kit have been observed in the skin of those affected. The diagnosis is established on clinical grounds and the findings on skin biopsy. Bone marrow studies are recommended if there is suspicion of progression of disease to an adult form, if cytoreductive therapy is contemplated, or if skin lesions remain present and/or tryptase levels remain elevated after puberty. The use of chemotherapy, including kinase inhibitors, is strongly discouraged unless severe hematologic disease is present, since malignant evolution is extremely rare.
Asunto(s)
Mastocitos/patología , Mastocitosis Cutánea/terapia , Urticaria Pigmentosa/terapia , Animales , Biopsia , Niño , Progresión de la Enfermedad , Humanos , Mastocitosis Cutánea/diagnóstico , Mastocitosis Cutánea/patología , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/patologíaRESUMEN
Mastocytosis is a heterogeneous group of rare diseases characterized by the proliferation and accumulation of mast cells in one or more organs such as the skin, bone marrow, liver, spleen, and lymph nodes. According to the WHO classification, mastocytosis is divided into seven subvariants. The symptoms are associated with mediator release and impaired organ function due to infiltration by neoplastic mast cells. There is a higher risk of anaphylactic shock; therefore education of the patients is very important. Patients may be asymptomatic. Symptomatic treatment is used in cutaneous mastocytosis and in indolent systemic mastocytosis. More aggressive subvariants of mastocytosis are treated with chemotherapy, targeted therapy, and bone marrow transplantation.
Asunto(s)
Mastocitos/inmunología , Mastocitosis/diagnóstico , Mastocitosis/terapia , Diagnóstico Diferencial , Humanos , Enfermedades del Sistema Inmune/clasificación , Enfermedades del Sistema Inmune/diagnóstico , Enfermedades del Sistema Inmune/terapia , Mastocitosis/clasificación , Mastocitosis/inmunología , Pronóstico , Enfermedades Raras , Piel/inmunología , Urticaria Pigmentosa/clasificación , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/terapia , Organización Mundial de la SaludRESUMEN
Recent advances in our understanding of mast cell biology and disease resulted in identification of important differences in expression of mast cell surface antigens in normal and neoplastic mast cells. Most notably, detection of aberrant expression of CD25 and CD2 on the surface of neoplastic mast cells but not on their normal counterparts leads to the inclusion of this immunophenotypic abnormality in the World Health Organization's diagnostic criteria for systemic mastocytosis. Aberrant mast cell surface marker expression can be detected in the bone marrow aspirate by flow cytometry, even in patients with limited disease that lacks histopathologically detectable aggregates of mast cells in bone marrow biopsy sections. Flow cytometric analysis of bone marrow mast cells is therefore a sensitive method of diagnosis of mast cell disease and is expected to find increasing use in determining response to emerging mast cell cytoreductive therapies.
Asunto(s)
Mastocitosis Sistémica/diagnóstico , Mastocitosis Sistémica/terapia , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/terapia , Biomarcadores de Tumor/biosíntesis , Biopsia , Médula Ósea/metabolismo , Médula Ósea/patología , Antígenos CD2/biosíntesis , Diagnóstico Diferencial , Regulación Neoplásica de la Expresión Génica , Inmunofenotipificación/métodos , Mastocitos/metabolismo , Mastocitos/patología , Mastocitosis Sistémica/metabolismo , Mastocitosis Sistémica/patología , Lectina 2 Similar a Ig de Unión al Ácido Siálico/biosíntesis , Urticaria Pigmentosa/metabolismo , Urticaria Pigmentosa/patologíaRESUMEN
Mastocytosis is a group of rare diseases characterized by abnormal growth of mast cells in skin, bone marrow, liver, spleen, lymph nodes. Signs and symptoms result mostly from mast cells mediators and mast cells organ infiltration. Pathological examination proving mast cells infiltration is crucial for the diagnosis of disease. Therapy covers patient education and symptomatic treatment (antihistamine drugs and glicocortycoids). Attempts of interferon, cladribine, imatinib treatment are made. Aggressive forms of diseases require, chemiotherapy, bone marrow transplantation. All mastocytosis subjects should be equipped in adrenaline. The paper describes case of 52 years old woman who suffered from urticaria pigmenthosa, anaphylaxis, insect venom and food allergy. Diagnosis included bone marrow examinations (pathology, cytology, genetics, cytofotometry) tryptase level, skin prick tests and sIgE. Mastocytosis was diagnosed. Therapy included symptomatic treatment and immunotherapy. The paper describes also aims of the European Competence Network on Mastocytosis.
Asunto(s)
Anafilaxia/inmunología , Anafilaxia/terapia , Mastocitos/metabolismo , Mastocitosis/inmunología , Mastocitosis/terapia , Venenos de Artrópodos/inmunología , Examen de la Médula Ósea/métodos , Femenino , Hipersensibilidad a los Alimentos/inmunología , Humanos , Hipersensibilidad/inmunología , Mastocitos/inmunología , Mastocitoma/inmunología , Mastocitosis/patología , Persona de Mediana Edad , Enfermedades Raras , Piel/inmunología , Piel/patología , Resultado del Tratamiento , Triptasas/metabolismo , Urticaria Pigmentosa/inmunología , Urticaria Pigmentosa/terapiaAsunto(s)
Urticaria Pigmentosa/diagnóstico , Adulto , Enfermedad Crónica , Humanos , Masculino , Urticaria Pigmentosa/terapiaRESUMEN
Paciente pediátrico, 6 meses, masculino, internado no Hospital Geral em Caxias do Sul. Apresentou lesões hipercrômicas maculopapulares descamativas, vermelho-acastanhadas, intensamente pruriginosas, atingindo grande parte do corpo. Recebeu anti-histamínicos e banhos de água e aveia, enquanto internado. Foi realizada biópsia de pele, que constatou quadro compatível com urticária pigmentosa (UP). A UP é a mais freqüente manifestação de mastocitose, ocorrendo na pele e caracterizando-se por lesões cutâneas com pigmentação persistente e pruriginosa. A mastocitose é caracterizada por um acúmulo local ou sistêmico de mastócitos, sendo que os sintomas, dentre os quais o principal é o prurido, resultam da liberação maciça de histamina e outros mediadores pelos mastócitos. O diagnóstico é baseado basicamente na história e apresentação clínica, com confirmação de envolvimento cutâneo por biópsia. Ainda não há tratamento definitivo e eficaz, e somente alívio sintomático pode ser atingido (AU)
Pediatric patient, 6 months old, male, admitted to General Hospital in Caxias do Sul. The patient displays hyperchromic maculopapular peeling lesions, reddish-brown, with intense itching extending over the majority of the body. The patient received anti-histamines and oat water baths while at the hospital. The results of a skin biopsy were indicative of urticaria pigmentosa (UP). UP is the most common manifestation of mastocytosis, occurring in the skin and characterized by cutaneous lesions with persistent and itching spots. Mastocytosis is characterized by a local or systemic accumulation of mast cells, accompanied by symptoms, among which the primary one is itching, resulting from the massive release of histamine and other mediators by the mast cells. Diagnosis is based basically on clinical history and examination, confirmed by cutaneous biopsy. There is still no satisfactory and efficient treatment, and only the symptoms can be alleviated (AU)
Asunto(s)
Humanos , Masculino , Lactante , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/terapia , Mastocitosis/diagnóstico , Mastocitosis/fisiopatología , Mastocitosis/terapia , Urticaria Pigmentosa/epidemiología , Mastocitos/patologíaRESUMEN
OBJECTIVE: To characterize the clinical features, response to therapy, evolution and prognosis of cutaneous mastocytosis in children. BACKGROUND: Mastocytosis in children, instead of being induced by a potentially oncogenic c-kit mutation, is probably a clonal disease with benign prognosis. METHODS: The clinicopathological features, evolution and response to treatment were analysed in 71 children with mastocytosis. RESULTS: There were 53 (75%) cases of urticaria pigmentosa, 12 (17%) cases of mastocytoma, and six (8%) cases of diffuse cutaneous mastocytosis. In 92% of cases disease onset was in the first year of life. There was a male predominance 1.8 : 1. Treatment did not modify the disease evolution. Eighty per cent of patients improved or had spontaneous resolution of the disease. CONCLUSION: The most frequent clinical form of mastocytosis was urticaria pigmentosa followed by mastocytoma and diffuse cutaneous mastocytosis. Darier's sign was present in 94% of cases. A negative Darier's sign does not rule out mastocytosis. In contrast to adults, mastocytosis in children usually has a benign course making sophisticated or invasive diagnostic tests unnecessary. A classification of paediatric cutaneous mastocytosis is proposed.